23 min listen
E48-DRCR Protocol W 2-year Results: Prophylactic anti-VEGF for Mod-Severe NPDR
E48-DRCR Protocol W 2-year Results: Prophylactic anti-VEGF for Mod-Severe NPDR
ratings:
Length:
32 minutes
Released:
Apr 20, 2021
Format:
Podcast episode
Description
Dr. Raj Maturi from the DRCR Retina Network discusses effect of early anti-VEGF injections in moderate-severe NPDR to prevent vision-threatening complications of diabetic retinopathy. This is the 2-year results of a 4-year study. Discussed article: Maturi RK, Glassman AR, Josic K, Antoszyk AN, Blodi BA, Jampol LM, Marcus DM, Martin DF, Melia M, Salehi-Had H, Stockdale CR, Punjabi OS, Sun JK; DRCR Retina Network. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol. 2021 Mar 30:e210606. doi: 10.1001/jamaophthalmol.2021.0606. Epub ahead of print. PMID: 33784735; PMCID: PMC8010644.
Released:
Apr 20, 2021
Format:
Podcast episode
Titles in the series (77)
Review of the Clarity Study: intravitreal aflibercept versus panretinal photocoagulation for proliferative diabetic retinopathy by The Retina Channel Podcast